PEPITES: A Double blind, Placebo controlled, Randomized Phase III Pivotal Trial to Assess the Efficacy and Safety of Peanut Epicutaneous ImmunoTherapy with Viaskin® Peanut in Peanut allergic Children

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/168/31/50

Funding

  • DBV Technologies